Sunday, October 21, 2018
- 9:00AM-11:00AM
-
Abstract Number: 448
Tizanidine, a Frequently Used Muscle Relaxant, Is Associated with Severe Hypotension: Role of Cytochrome P450 1A2 Inhibition in Routine Clinical Practice
Pain Mechanisms – Basic and Clinical Science Poster- 9:00AM-11:00AM
-
Abstract Number: 692
TNF Inhibitor Dose Tapering in Axial Spondyloarthritis: A Systematic Review and Meta-Analysis
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging, Clinical Studies, and Treatment- 9:00AM-11:00AM
-
Abstract Number: 233
TNF Inhibitors: Prevalence of Use and Predictors of Treatment Non-Persistence in the 2011-2016 Medicare Population
Epidemiology and Public Health Poster I: Rheumatoid Arthritis- 9:00AM-11:00AM
-
Abstract Number: 63
TNF-α Blockade Incompletely Reverses Inflammatory Pulmonary Pathology in the TNF-Transgenic Mouse Model of Rheumatoid Arthritis
Rheumatoid Arthritis – Animal Models Poster- 9:00AM-11:00AM
-
Abstract Number: 767
Tobacco and Systemic Lupus Erythematosus Relationships: Pay Attention to the Retina!
Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity- 9:00AM-11:00AM
-
Abstract Number: 49
Tofacitinib Facilitates the Expansion of Myeloid-Dirived Suppressor Cells and Ameliorates Interstitial Lung Disease in SKG Mice
Rheumatoid Arthritis – Animal Models Poster- 9:00AM-11:00AM
-
Abstract Number: 27
Top-Down Proteomics Coupled with Antibody Sequencing from Single B Cells Reveals a Monoclonal Anti-Sm Clone Present in the Serum of an SLE Patient over Three Years
B Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 444
Trajectories of Sport or Recreational Activities over Eight Years and Associated Factors in Persons at Risk for Knee Osteoarthritis
Osteoarthritis – Clinical Poster I- 9:00AM-11:00AM
-
Abstract Number: 803
Treating Interstitial Lung Disease and Skin Involvement in Systemic Sclerosis with Oral Versus Intravenous Cyclophosphamide: Preliminary Efficacy and Safety Data from 2 Randomized Clinical Trials and 1 Registry
Systemic Sclerosis and Related Disorders – Clinical Poster I- 9:00AM-11:00AM
-
Abstract Number: 556
Treatment Initiation and Duration in DMARD Naïve Rheumatoid Arthritis Patients: Analysis of US Health Plan Claims
Rheumatoid Arthritis – Treatments Poster I: Strategy and Epidemiology- 9:00AM-11:00AM
-
Abstract Number: 23
Treatment with Immune Checkpoint Inhibitors and the Development of Autoantibodies
B Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 434
Trends in Procedure Type, Patient Characteristics, and Outcomes Among Persons with Knee Osteoarthritis Undergoing Bariatric Surgery, 2005-2014
Osteoarthritis – Clinical Poster I- 9:00AM-11:00AM
-
Abstract Number: 498
Trends in the Incidence of Cardiovascular Diseases in Patients with Rheumatoid Arthritis in Spain: A National Observational Cohort Study of Hospital Discharges
Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I: Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 493
Trends in the Incidence of SOLID Tumors in Patients with Rheumatoid Arthritis in Spain. a National Observational Cohort Study